Veerapol Kukongviriyapan

6PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targetsChemotherapyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 31, 2022
Epidermal growth factor receptor as a potential target of momordin Ic to promote apoptosis of cholangiocarcinoma cells.

Laddawan Senggunprai, Veerapol Kukongviriyapan, Auemduan Prawan

|Jan 29, 2022
Licochalcone A Induces Cholangiocarcinoma Cell Death Via Suppression of Nrf2 and NF-κB Signaling Pathways.

Phatthamon Laphanuwat, Sarinya Kongpetch, Laddawan Senggunprai

|Jun 04, 2021
Derrischalcone suppresses cholangiocarcinoma cells through targeting ROS-mediated mitochondrial cell death, Akt/mTOR, and FAK pathways.

Jaroon Wandee, Piyarat Srinontong, Auemduan Prawan

|Feb 28, 2021
The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.

Papavee Samatiwat, Lueacha Tabtimmai, Prapasiri Suphakun

|Jan 28, 2021
Cucurbitacin B Diminishes Metastatic Behavior of Cholangiocarcinoma Cells by Suppressing Focal Adhesion Kinase.

Putthaporn Kaewmeesri, Veerapol Kukongviriyapan, Auemduan Prawan

|May 09, 2020
Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.

Rattanaporn Jaidee, Sarinya Kongpetch, Laddawan Senggunprai

Pageof 1